[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"erythema-migrans\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:erythema-migrans":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,44],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":28,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":43},"100321243","patients-pretreatment-expectations-about-post-lyme-symptoms-100321243",false,"NCT03462329","Patient's Pretreatment Expectations About Post-Lyme Symptoms","Impact of Patient's Pretreatment Expectations on Treatment Outcome of Early Lyme Borreliosis","Inclusion Criteria:\n\n* erythema migrans\n\nExclusion Criteria:\n\n* pregnancy or lactation\n* immunocompromised\n* taking antibiotic with antiborrelial activity within 10 days",true,"ALL","18 Years",{"count":20,"type":21},200,"ESTIMATED","INTERVENTIONAL",[24],"NA","The investigators will focus on pretreatment expectations of patients with early Lyme disease manifested as erythema migrans with the aim of assessing the association between pretreatment expectations quantified with a questionnaire and treatment outcome quantified with the presence of post-Lyme symptoms. Furthermore, the investigators will compare the prevalence of nonspecific symptoms among patients and among age-matched controls without a history of Lyme borreliosis.",[27],"Erythema Migrans",[29,30],"Post-Lyme symptoms","Pretreatment expectations","RECRUITING","2026-04-27",{"date":34,"type":35},"2026-04-29","ACTUAL",{"date":37,"type":35},"2018-06-01",{"date":39,"type":21},"2028-12-01",{"name":41,"class":42},"University Medical Centre Ljubljana","OTHER",1,{"id":45,"slug":46,"hasResults":11,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":4,"eligibilityCriteria":50,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":51,"targetDuration":4,"studyType":22,"phases":52,"briefSummary":54,"conditions":55,"keywords":4,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":56,"lastUpdatePostDateStruct":57,"startDateStruct":59,"completionDateStruct":61,"leadSponsor":63,"locationsCount":5},"100359893","phase-3-different-amoxicillin-treatment-regimens-in-erythema-migrans-patients-100359893","NCT03966014","Different Amoxicillin Treatment Regimens in Erythema Migrans Patients","Different Duration and Dosing of Amoxicillin in Patients With Erythema Migrans. A Randomized Clinical Trial.","Inclusion Criteria:\n\n* erythema migrans\n\nExclusion Criteria:\n\n* pregnancy\n* extracutaneous manifestations of Lyme borreliosis\n* immunocompromising state\n* serious adverse event to beta lactam antibiotic\n* receiving antibiotic with antiborrelial activity within 10 days",{"count":20,"type":21},[53],"PHASE3","The purpose of this study is to compare the efficacy of different amoxicilline treatment regimens in patients with erythema migrans.",[27],"2026-03-22",{"date":58,"type":35},"2026-03-25",{"date":60,"type":35},"2019-06-01",{"date":62,"type":21},"2027-12-31",{"name":41,"class":42}]